Clinical Trial Update: A Study of AK111 in Subjects With Moderate-to-severe Plaque Psoriasis [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating AK111 for moderate-to-severe plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• AK111

Snippet

Sponsor: Akeso | Conditions: Psoriasis | Phase 1 | Status: COMPLETED